Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kessler

Showing results (81-90 of 1,889) with videos related to

Pageof 189
Sort By:
Annals of Internal Medicine|June 19, 2002
The CONSORT statement: explanation and elaboration. Consolidated Standards of Reporting TrialsKenneth M Kessler
Seminars in Hematology|June 11, 2004
Propensity for hemorrhage and thrombosis in chronic myeloproliferative disordersCraig M Kessler
Seminars in Hematology|April 1, 1994
Factor VIII inhibitors--an algorithmic approach to treatmentC M Kessler
Journal of the American College of Cardiology|February 1, 1990
Predictors of left ventricular thrombus formation: flow, asynergy and morphologyK M Kessler
Physical Therapy|August 1, 1979
Acute symptomatic disk prolapse. Clinical manifestations and therapeutic considerationsR M Kessler
The Medical Clinics of North America|September 1, 1974
Individualization of dosage of antiarrhythmic drugsK M Kessler
Best Practice & Research. Clinical Haematology|June 3, 2004
Antidotes to haemorrhage: recombinant factor VIIaCraig M Kessler
Journal of the American College of Cardiology|March 1, 2005
Should the lack of feasibility of conducting controlled trials influence evidence-based guidelines?Kenneth M Kessler
Expert Review of Proteomics|April 13, 2006
Putting proteomics on target: activity-based profiling of ubiquitin and ubiquitin-like processing enzymesBenedikt M Kessler
Journal of the American College of Cardiology|January 1, 1992
Syndrome X: the epicardial viewK M Kessler
Pageof 189

Showing results (81-90 of 1,889) with videos related to

Sort By:
Pageof 189
Annals of Internal Medicine|June 19, 2002
The CONSORT statement: explanation and elaboration. Consolidated Standards of Reporting TrialsKenneth M Kessler
Seminars in Hematology|June 11, 2004
Propensity for hemorrhage and thrombosis in chronic myeloproliferative disordersCraig M Kessler
Seminars in Hematology|April 1, 1994
Factor VIII inhibitors--an algorithmic approach to treatmentC M Kessler
Journal of the American College of Cardiology|February 1, 1990
Predictors of left ventricular thrombus formation: flow, asynergy and morphologyK M Kessler
Physical Therapy|August 1, 1979
Acute symptomatic disk prolapse. Clinical manifestations and therapeutic considerationsR M Kessler
The Medical Clinics of North America|September 1, 1974
Individualization of dosage of antiarrhythmic drugsK M Kessler
Best Practice & Research. Clinical Haematology|June 3, 2004
Antidotes to haemorrhage: recombinant factor VIIaCraig M Kessler
Journal of the American College of Cardiology|March 1, 2005
Should the lack of feasibility of conducting controlled trials influence evidence-based guidelines?Kenneth M Kessler
Expert Review of Proteomics|April 13, 2006
Putting proteomics on target: activity-based profiling of ubiquitin and ubiquitin-like processing enzymesBenedikt M Kessler
Journal of the American College of Cardiology|January 1, 1992
Syndrome X: the epicardial viewK M Kessler
Pageof 189